Shine Investment Advisory Services’s Vertex Pharmaceuticals VRTX Stock Holding History

Shine Investment Advisory Services’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	$4K	Hold	14	–	–	﹤0.01%	663
2020 Q2	$4K	Hold	14	–	–	﹤0.01%	674
2020 Q1	$3K	Hold	14	–	–	﹤0.01%	665
2019 Q4	$3K	Hold	14	–	–	﹤0.01%	698
2019 Q3	$2K	Hold	14	–	–	﹤0.01%	703
2019 Q2	$3K	Hold	14	–	–	﹤0.01%	655
2019 Q1	$3K	Buy	+14	New	+$2.59K	﹤0.01%	665
2018 Q1	–	Sell	-67	Closed	-$10K	–	672
2017 Q4	$10K	Buy	67 +14	+26%	+$2.07K	0.01%	533
2017 Q3	$8K	Sell	53 -27	-34%	-$4.06K	﹤0.01%	573
2017 Q2	$10K	Buy	+80	New	+$9.63K	0.01%	520

Other funds holding VRTX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Shine Investment Advisory Services's VRTX Position: Q3 2020 in Review

Shine Investment Advisory Services held its Vertex Pharmaceuticals (VRTX) position steady in Q3 2020 at 14 shares worth $4K. The position accounts for ﹤0.01% of the portfolio, ranked #663.

Shine Investment Advisory Services first reported a position in VRTX in Q2 2017 and has held it in 10 quarters since. The position peaked at $10K in Q4 2017. 951 funds tracked by Wall St. Rank hold VRTX as of Q3 2020.

Shine Investment Advisory Services held 14 shares of Vertex Pharmaceuticals worth $4K as of Q3 2020.
Shine Investment Advisory Services left its Vertex Pharmaceuticals share count unchanged in Q3 2020.
Vertex Pharmaceuticals made up ﹤0.01% of Shine Investment Advisory Services's portfolio in Q3 2020, its #663 holding.
Shine Investment Advisory Services first reported a position in Vertex Pharmaceuticals in Q2 2017 and has held it in 10 quarters since.
Shine Investment Advisory Services's Vertex Pharmaceuticals position peaked at $10K in Q4 2017.
951 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2020.

Based on Shine Investment Advisory Services's 13F filing for Q3 2020, filed 3 Nov 2020.